Structural visualizations illuminate remdesivir’s mechanism of action

In a new study, researchers report the structure of remdesivir — an antiviral drug that has shown promise against the SARS-CoV-2 virus in lab studies and early clinical trials — bound to both a molecule of RNA and to the viral polymerase.